Boehringer Ingelheim (Germany)
In research, Boehringer Ingelheim (Germany) stands highest in Health Sciences (#825 of 9,902 worldwide), Medicine (#821 of 8,541 worldwide) and Life Sciences (#905 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Veterinary, Small Animals and Nephrology (Veterinary is 13.8× its share of world research).
- World rank, 2022-now
- #1,779 of 22,385 · #1,223 all time
- Rank in Germany
- #84 of 795
- Research works
- 9.3k ▲ 6% vs 2018-21
- Citations
- 302k 32.3 per fractional work
- Top-10% rate
- 12.4% all institutions 10.0%
- vs its own fields
- 1.00× 1.00× is exactly expected
- Open access
- 37% world 40%
- International
- 46% world 18%
What is Boehringer Ingelheim (Germany) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #825 of 9,902 | 14.7% | 688 | #715 | |
| MedicineField | #821 of 8,541 | 14.8% | 632 | #681 | |
| Life SciencesDomain | #905 of 6,403 | 11.1% | 475 | #693 | |
| Biochemistry, Genetics and Molecular BiologyField | #712 of 2,964 | 13.3% | 254 | #661 | |
| Physical SciencesDomain | #3,215 of 10,670 | 10.8% | 230 | #2105 | |
| Molecular BiologySubfield | #594 of 1,880 | 14.6% | 186 | #585 | |
| Pulmonary and Respiratory MedicineSubfield | #470 of 1,037 | 16.2% | 113 | #392 | |
| ChemistryField | #696 of 1,299 | 9.2% | 75 | #573 | |
| OncologySubfield | #421 of 755 | 12.1% | 66 | #470 | |
| Immunology and MicrobiologyField | #437 of 681 | 10.3% | 91 | #396 |
Each strip is that field's whole ranked pool, with the notch where Boehringer Ingelheim (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#715 #825
- Medicine#681 #821
- Life Sciences#693 #905
- Biochemistry, Genetics and Molecular Biology#661 #712
- Physical Sciences#2,105 #3,215
- Molecular Biology#585 #594
- Pulmonary and Respiratory Medicine#392 #470
- Chemistry#573 #696
- Oncology#470 #421
- Immunology and Microbiology#396 #437
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Boehringer Ingelheim (Germany) work in?
In 2022-now, 47% of research at Boehringer Ingelheim (Germany) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (6%). It does 2.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences78147.1%
- Medicine72143.4%
- Veterinary311.9%
- Health Professions241.4%
- Nursing40.2%
- Dentistry20.1%
- Life Sciences53432.2%
- Physical Sciences25315.3%
- Chemistry814.9%
- Engineering563.4%
- Computer Science362.2%
- Environmental Science271.6%
- Materials Science231.4%
- Mathematics191.1%
- Physics and Astronomy60.3%
- Chemical Engineering30.2%
- Energy20.1%
- Earth and Planetary Sciences10.1%
- Social Sciences915.5%
- Economics, Econometrics and Finance271.6%
- Psychology261.6%
- Social Sciences140.9%
- Decision Sciences90.6%
- Business, Management and Accounting80.5%
- Arts and Humanities60.4%
What does Boehringer Ingelheim (Germany) specialise in?
Where its research is concentrated relative to its size: Veterinary takes 13.8× the share of its output that it takes of world research.
- VeterinaryField · 31.2 works14×
- Small AnimalsSubfield · 28.1 works14×
- NephrologySubfield · 31.8 works8.8×
- ImmunologySubfield · 76.2 works6.7×
- Endocrinology, Diabetes and MetabolismSubfield · 59.5 works6.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 13.8×. Every wedge is a field page.
All 26 fields, with their numbers
- Veterinary13.82×31 works
- Pharmacology, Toxicology and Pharmaceutics6.46×38 works
- Immunology and Microbiology5.98×100 works
- Biochemistry, Genetics and Molecular Biology3.25×287 works
- Chemistry3.12×81 works
- Medicine2.26×721 works
- Neuroscience1.48×40 works
- Mathematics0.96×19 works
- Agricultural and Biological Sciences0.88×69 works
- Economics, Econometrics and Finance0.75×27 works
- Decision Sciences0.59×10 works
- Health Professions0.55×24 works
- Psychology0.52×26 works
- Chemical Engineering0.48×3 works
- Nursing0.45×4 works
- Materials Science0.40×23 works
- Environmental Science0.33×27 works
- Computer Science0.28×36 works
- Dentistry0.23×2 works
- Engineering0.22×56 works
- Physics and Astronomy0.16×6 works
- Business, Management and Accounting0.16×8 works
- Energy0.14×2 works
- Arts and Humanities0.13×6 works
- Social Sciences0.07×14 works
- Earth and Planetary Sciences0.03×1 works
- Veterinary 13.8×
- Pharmacology, Toxicology and Pharmaceutics 6.5×
- Immunology and Microbiology 6.0×
- Biochemistry, Genetics and Molecular Biology 3.2×
- Chemistry 3.1×
- Medicine 2.3×
- Neuroscience 1.5×
- Mathematics 1.0×
- Agricultural and Biological Sciences 0.9×
- Economics, Econometrics and Finance 0.8×
- Decision Sciences 0.6×
- Health Professions 0.6×
- Psychology 0.5×
- Chemical Engineering 0.5×
- Nursing 0.5×
- Materials Science 0.4×
- Environmental Science 0.3×
- Computer Science 0.3×
- Dentistry 0.2×
- Engineering 0.2×
- Physics and Astronomy 0.2×
- Business, Management and Accounting 0.2×
- Energy 0.1×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Boehringer Ingelheim (Germany)?
Ranked on the quality score, Uli C. Broedl, Hans Juergen Woerle and Erich Bluhmki lead among researchers whose main affiliation is Boehringer Ingelheim (Germany).
- 1
Uli C. Broedl
Germany · #25,027 worldwide 33k citations · 151 works
- 2
Hans Juergen Woerle
Germany · #29,149 worldwide 18k citations · 102 works
- 3
Erich Bluhmki
Germany · #41,000 worldwide 44k citations · 111 works
- 4
Cordula Zeller
Germany · #73,274 worldwide 15k citations · 59 works
- 5
Waheed Jamal
Germany · #77,246 worldwide 15k citations · 39 works
- 6
Afshin Salsali
Germany · #86,218 worldwide 7.2k citations · 94 works
- 7
Joachim Stangier
Germany · #101,513 worldwide 13k citations · 75 works
- 8
Stefan Hantel
Germany · #109,828 worldwide 21k citations · 93 works
- 9
Janet M. Schnee
Germany · #130,087 worldwide 19k citations · 56 works
- 10
Susanne Stowasser
Germany · #144,773 worldwide 17k citations · 226 works
Which keywords describe research at Boehringer Ingelheim (Germany)?
By fractional works in 2022-now, weighted toward what it does more of than the world: TGF-ß, Fibrosis, Epidemiology, Heart Failure, Monoclonal Antibodies, Glycosylation, Interstitial Lung Disease and Epithelial-Mesenchymal Transition.
- Gene Therapy
- Fc Receptors
- Recombinant Protein
- Biopharmaceutical Production
- Medicinal Chemistry
- Cell Culture
- Pharmacokinetics
- Immunogenicity
- Chronic Kidney Disease
- Cardiovascular Outcomes
- Pathogenesis
- Clinical Guidelines
- Diagnosis
- Myofibroblast
- Therapeutic Antibodies
- Interstitial Lung Disease
- Glycosylation
- Monoclonal Antibodies
- Inflammation
- TGF-ß
- Epidemiology
- Fibrosis
- Heart Failure
- Cardiovascular Disease
- Treatment
- Epithelial-Mesenchymal Transition
- Idiopathic Pulmonary Fibrosis
- Glycemic Control
- Insulin Therapy
- Type 2 Diabetes
- Biopharmaceuticals
- Glucose Control
- Global Burden
- Monoclonal Antibody
- Autoantibodies
- Immunosuppressive Therapy
- Immune System
- Mammalian Cells
- Antibody Engineering
- Recombinant Proteins
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology143▲ 2.2×103 topics
- TGF-ß88▲ 33×4 topics
- Fibrosis88▲ 27×7 topics
- Inflammation79▲ 2.2×71 topics
- Heart Failure72▲ 9.7×13 topics
- Monoclonal Antibodies64▲ 43×3 topics
- Cardiovascular Disease62▲ 3.3×28 topics
- Glycosylation57▲ 31×3 topics
- Treatment57▲ 2.8×37 topics
- Interstitial Lung Disease57▲ 52×2 topics
- Epithelial-Mesenchymal Transition54▲ 33×2 topics
- Therapeutic Antibodies52▲ 45×2 topics
- Idiopathic Pulmonary Fibrosis52▲ 65×1 topic
- Myofibroblast52▲ 65×1 topic
- Glycemic Control50▲ 19×4 topics
- Diagnosis49▲ 3.2×31 topics
- Insulin Therapy49▲ 24×3 topics
- Clinical Guidelines49▲ 9.9×7 topics
- Type 2 Diabetes42▲ 11×4 topics
- Pathogenesis41▲ 4.8×20 topics
- Biopharmaceuticals39▲ 46×3 topics
- Cardiovascular Outcomes38▲ 40×1 topic
- Glucose Control38▲ 40×1 topic
- Chronic Kidney Disease38▲ 9.1×9 topics
- Global Burden38▲ 4.2×10 topics
- Immunogenicity38▲ 53×3 topics
- Monoclonal Antibody37▲ 41×2 topics
- Pharmacokinetics35▲ 8.0×11 topics
- Autoantibodies33▲ 8.4×7 topics
- Cell Culture32▲ 17×3 topics
- Immunosuppressive Therapy31▲ 9.7×7 topics
- Medicinal Chemistry30▲ 6.7×9 topics
- Immune System28▲ 7.2×8 topics
- Biopharmaceutical Production27▲ 42×2 topics
- Mammalian Cells27▲ 71×1 topic
- Recombinant Protein27▲ 71×1 topic
- Antibody Engineering27▲ 29×1 topic
- Fc Receptors27▲ 29×1 topic
- Recombinant Proteins26▲ 50×2 topics
- Gene Therapy26▲ 8.2×6 topics
Which research topics does Boehringer Ingelheim (Germany) publish most on?
By volume in 2022-now: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Diabetes Treatment and Management, Viral Infectious Diseases and Gene Expression in Insects and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 52 works
- 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 38 works
- 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 27 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 27 works
- 5 Protein purification and stability Molecular Biology 25 works
- 6 Psoriasis: Treatment and Pathogenesis Immunology 18 works
- 7 Computational Drug Discovery Methods Computational Theory and Mathematics 18 works
- 8 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 18 works
- 9 Virus-based gene therapy research Genetics 16 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 16 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Boehringer Ingelheim (Germany)'s research output changed?
Output in 2022-2025 was 6% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Boehringer Ingelheim (Germany) as a percentage of every work published that year, 0.0071% in 2024.
Fractional works of Boehringer Ingelheim (Germany) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.1% in 1990.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Boehringer Ingelheim (Germany). Posts are plain text and can be reported.
